Bruns Ingmar — SEC Form 4 filings

SEC reporting owner CIK 1838041. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-10.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-12-03 to 2026-02-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zentalis Pharmaceuticals, Inc. (ZNTL)Chief Medical Officer51 leg · 20,000 sh · $45,6562 legs · 3,297 sh · $7,9984

Form 4 filings — Bruns Ingmar

FiledFormIssuerReported transactionsSource
2026-02-104Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 2,962 @ $2.43 · Sale (S): 335 @ $2.39EDGAR
2026-01-094Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 365,000 (derivative) @ $0EDGAR
2025-02-124Zentalis Pharmaceuticals, Inc. (ZNTL)Purchase (P): 20,000 @ $2.28EDGAR
2025-02-054Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 16,629 @ $0 · Grant/award (A): 16,629 (derivative) @ $0EDGAR
2024-12-034Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 712,650 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1838041 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →